Erin Reed-Geaghan - Publications

Affiliations: 
Pharmaceutical Sciences Northeast Ohio Medical University; Kent State University 

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Casali BT, MacPherson KP, Reed-Geaghan EG, Landreth GE. Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies. Neurobiology of Disease. 104956. PMID 32479996 DOI: 10.1016/j.nbd.2020.104956  0.705
2020 Reed-Geaghan EG, Croxford AL, Becher B, Landreth GE. Plaque-associated myeloid cells derive from resident microglia in an Alzheimer's disease model. The Journal of Experimental Medicine. 217. PMID 31967645 DOI: 10.1084/jem.20191374  0.67
2018 Cheng-Hathaway PJ, Reed-Geaghan EG, Jay TR, Casali BT, Bemiller SM, Puntambekar SS, von Saucken VE, Williams RY, Karlo JC, Moutinho M, Xu G, Ransohoff RM, Lamb BT, Landreth GE. The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer's disease. Molecular Neurodegeneration. 13: 29. PMID 29859094 DOI: 10.1186/S13024-018-0262-8  0.634
2018 Casali BT, Reed-Geaghan EG, Landreth GE. Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer's disease. Journal of Neuroinflammation. 15: 43. PMID 29448961 DOI: 10.1186/s12974-018-1091-y  0.651
2012 Wilkinson BL, Cramer PE, Varvel NH, Reed-Geaghan E, Jiang Q, Szabo A, Herrup K, Lamb BT, Landreth GE. Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's disease. Neurobiology of Aging. 33: 197.e21-32. PMID 20696495 DOI: 10.1016/J.Neurobiolaging.2010.06.014  0.605
2010 Reed-Geaghan EG, Reed QW, Cramer PE, Landreth GE. Deletion of CD14 attenuates Alzheimer's disease pathology by influencing the brain's inflammatory milieu. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 15369-73. PMID 21084593 DOI: 10.1523/Jneurosci.2637-10.2010  0.618
2009 Reed-Geaghan EG, Savage JC, Hise AG, Landreth GE. CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 11982-92. PMID 19776284 DOI: 10.1523/JNEUROSCI.3158-09.2009  0.62
2009 Landreth GE, Reed-Geaghan EG. Toll-like receptors in Alzheimer's disease. Current Topics in Microbiology and Immunology. 336: 137-53. PMID 19688332 DOI: 10.1007/978-3-642-00549-7_8  0.716
2007 Zelcer N, Khanlou N, Clare R, Jiang Q, Reed-Geaghan EG, Landreth GE, Vinters HV, Tontonoz P. Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors. Proceedings of the National Academy of Sciences of the United States of America. 104: 10601-6. PMID 17563384 DOI: 10.1073/Pnas.0701096104  0.71
Show low-probability matches.